Abstract
Colorectal carcinoma is uncommon in Egypt, but a high proportion of cases occurs before age 40 years and in the rectum. We compared the molecular pathology of 59 representative Egyptian patients aged 10–72 to Western patients with sporadic, young-onset, or hereditary non-polyposis colorectal cancer syndrome (HNPCC)-associated carcinoma and found significant differences. Most Egyptian cancers were rectal (51%) and poorly differentiated (58%). High levels of microsatellite instability (MSI-H) were frequent (37%) and attributable in some cases (36%) to methylation of the promoter of the hMLH1 mismatch repair gene, but no MSI-H cancer had loss of hMSH2 mismatch repair gene product of the type seen with germline hMSH2 mutation in HNPCC. K-ras mutation was uncommon (11%). In subset analyses, high frequencies of MSI-H in rectal carcinomas (36%) and p53 gene product overexpression in MSI-H cancers (50%) were found. MSI-H and K-ras mutation in Egyptians under age 40 were unusual (17% and 0%, respectively), and schistosomiasis was associated with MSI and K-ras mutation. Cluster analysis identified 2 groups: predominantly young men with poorly differentiated mucinous and signet-ring cell colorectal carcinoma lacking K-ras mutation; older patients who had well- or moderately differentiated adenocarcinoma often with MSI-H, K-ras mutation and schistosomiasis. Our findings show that the molecular pathology of colorectal cancer in older as well as younger Egyptians has unique differences from Western patients, and schistosomiasis influences the molecular pathogenesis of some tumours. © 2001 Cancer Research Campaign http://www.bjcancer.com
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Abe Y and Masuda H (2000) Genetic alterations of sporadic colorectal cancer with microsatellite instability, especially characteristics of primary multiple colorectal cancers. J Surg Oncol 74: 249–256
Adib SM, Mufarrij AA, Shamseddine AI, Kahwaji SG, Issa P and El-Saghir NS (1998) Cancer in Lebanon: an epidemiological review of the American University of Beirut Medical Center Tumor Registry (1983–1994). Annal Epidemiol 8: 46–51
Adloff M, Arnaud J-P, Schloegel M, Thibaud D and Bergamaschi R (1986) Colorectal cancer in patients under 40 years of age. Dis Colon Rect 29: 322–325
Akhurst RJ and Balmain A (1999) Genetic events and the role of TGF beta in epithelial tumour progression. J Pathol 187: 82–90
Alawi MA, Ammari N and Shuraiki Y (1992) Organochlorine pesticide contaminations in human milk samples from women living in Amman, Jordan. Arch Env Contamin Toxicol 23: 235–239
Al-Jaberi TM, Ammari F, Gharieybeh K, Khammash M, Yaghan RJ, Heis H, Al-Omari M and Al-Omari N (1997) Colorectal adenocarcinoma in a defined Jordanian population from 1990 to 1995. Dis Colon Rect 40: 1089–1094
Al-Saleh I, Echeverria-Quevedo A, Al-Dgaither S and Faris R (1998) Residue levels of organochlorinated insecticides in breast milk: a preliminary report from Al-Kharj, Saudi Arabia. J Env Path Toxicol Oncol 17: 37–50
Anderberg MR (1973) Cluster Analysis for Applications. Academic Press, New York
Baas IO, Mulder JW, Offerhaus GJ, Vogelstein B and Hamilton SR (1994) An evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in archival colorectal neoplasms. J Pathol 172: 5–12
Bedikian AY, Kantarjian H, Nelson RS, Stroehlein JR and Bodey GP (1981) Colorectal cancer in young adults. South Med J 74: 920–924
Boland CR, Thibodeau SN, Hamilton SR, Sidransky D, Eshleman JR, Burt RW, Meltzer SJ, Rodriguez-Bigas MA, Fodde R, Ranzani GN and Srivastava S (1998) A National Cancer Institute workshop on microsatellite instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 58: 5248–5257
Boytchev H, Marcovic S and Oettle GJ (1999) The characteristics of large bowel cancer in the low-risk population of the Witwatersrand. J Royal Coll Surg Edin 44: 366–370
Breivik J, Lothe RA, Meling GI, Rognum TO, Borresen-Dale AL and Gaudernack G (1997) Different genetic pathways to proximal and distal colorectal cancer influenced by sex related factors. Int J Cancer 74: 664–669
Calin GA, Gafa R, Tibileti MG, Herlea V, Becheanu G, Cavazzini L, Barbanti-Brodano G, Nenci I, Negrini M and Lanza G (2000) Genetic progression in microsatellite instability high (MSI-H) colon cancers correlates with clinico-pathological parameters: A study of the TGRbetaRII, BAX, hMSH3, hMSH6, IGFIIR and BLM genes. Int J Cancer 89: 230–235
Chan TL, Yuen ST, Chung LP, Ho JWC, Kwan ASY, Ho JCY, Leung SY and Wyllie AH (1999) Frequent microsatellite instability and mismatch repair gene mutations in young Chinese patients with colorectal cancer. J Natl Cancer Inst 91: 1221–1226
Chen MC, Chang PY, Chuang CY, Chen YJ, Wang FP, Tang YC and Chou SC (1981) Colorectal cancer and schistosomiasis. Lancet 1: 971–973
Cox LS (1997) Multiple pathways control cell growth and transformation: Overlapping and independent activities of p53 and p21Cip1/WAF1/Sdi1. J Pathol 183: 134–140
Curtale F, Nabil M, El-Wakeel A and Shamy MY (1998) Anemia and intestinal parasitic infections among school age children in Behera Governorate, Egypt. J Trop Ped 44: 323–328
Dietmaier W, Wallinger S, Bocker T, Kullmann F, Fishel R and Ruschoff J (1997) Diagnostic microsatellite instability: definition and correlation with mismatch repair protein expression. Cancer Res 57: 5248–5257
Dieumegard B, Grandjouan S, Sabourin J-C, Le Bihan M-L, Lefrere I, Bellefqih,, Pignon J-P, Rougier P, Lasser P, Benard J, Couturier D and Bressac-de Paillerets B (2000) Extensive molecular screening for hereditary non-polyposis colorectal cancer. Br J Cancer 82: 871–880
Ding HF and Fisher DE (1998) Mechanisms of p53-mediated apoptosis. Crit Rev Oncol 9: 83–98
El-Khoby T, Galal N, Fenwick A, Barakat R, El-Hawey A, Nooman Z, Habib M, Abdel-Wahab F, Gabr NS, Hammam HM, Hussein MH, Mikhail NN, Cline BL and Strickland GT (2000) The epidemiology of schistosomiasis in Egypt: Summary findings in nine governorates. Am J Trop Med Hyg 62: 88–89
Forster S, Sattler HP, Hack M, Romanakis K, Rohde V, Seitz G and Wullich B (1998) Microsatellite instability in sporadic carcinomas of the proximal colon: association with diploid DNA content, negative protein expression of p53, and distinct histopathologic features. Surgery 123: 13–18
Fujiwara T, Stolker JM, Watanabe T, Rashid A, Longo P, Eshleman JR, Booker S, Lynch HT, Jass JR, Green JS, Kim H, Jen J, Vogelstein B and Hamilton SR (1998) Accumulated clonal genetic alterations in familial and sporadic colorectal carcinomas with widespread instability in microsatellite sequences. Am J Pathol 153: 1063–1078
Genuardi M, Anti M, Capozzi E, Leonardi F, Fornasarig M, Novella E, Bellacosa A, Valenti A, Gabarrini GB, Roncucci L, Benatti P, Percesepe A, Ponz de Leon M, Coco C, de Paoli A, Valentini M, Boiocchi M, Neri G and Viel A (1998) MLH1 and MSH2 constitutional mutations in colorectal cancer families not meeting the standard criteria for hereditary nonpolyposis colorectal cancer. Int J Cancer 75: 835–839
Greenlee RT, Murray T, Bolden S and Wingo PA (2000) Cancer Statistics, 2000. CA Cancer J 49: 8–31
Gryfe R, Swallow C, Bapat B, Redston M, Gallinger S and Couture J (1997) Molecular biology of colorectal cancer. Curr Probl Cancer 21: 233–300
Hainaut P, Hernandez T, Robinson A, Rodriguez-Tome P, Floures T, Holstein M, Harris CC and Montesano R (1998) IARC database of p53 mutations in human tumors on cell lines: Update compilation, revised formats and new visualization tools. Nucleic Acids Res 26: 205–213
Herman JG, Graff JR, Myohanen S, Nelkin BD and Baylin SB (1996) Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 93: 9821–9826
Herman JG, Umar A, Polyak K, Graff JR, Ahuja N, Issa JP, Markowitz S, Willson JK, Hamilton SR, Kinzler KW, Kane MF, Kolodner RD, Vogelstein B, Kunkel TA and Baylin SB (1998) Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma. Proc Natl Acad Sci USA 95: 6870–6875
Heys SD, O'Hanrahan TJ, Brittenden J and Eremin O (1994) Colorectal cancer in young patients: a review of the literature. Eur J Surg Oncol 20: 225–231
Iino H, Jass JR, Simms LA, Young J, Leggett B, Ajioka Y and Watanabe H (1999) DNA microsatellite instability in hyperplastic polyps, serrated adenomas, and mixed polyps: A mild mutator pathway for colorectal cancer?. J Clin Pathol 52: 5–9
Ilyas M, Straub J, Tomlinson IP and Bodmer WF (1999) Genetic pathways in colorectal and other cancers. Eur J Cancer 35: 1986–2002
International Agency for Research on Cancer (1994) Schistosomes, Liver Flukes and Helicobacter pylori. IARC Monog Eval Carcin Risk Hum 61: 68–100
Ionov Y, Peinado MA, Malkhosyan S, Shibata D and Perucho M (1993) Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinognesis. Nature 363: 558–561
Isbister W (1992) Colorectal cancer below age 40 in the Kingdom of Saudi Arabia. Aust NZJ Surg 62: 468–472
Jass JR (1995) Colorectal adenoma progression and genetic change: Is there a link?. Ann Med 27: 301–306
Jass JR, Biden KG, Cummings MC, Simms LA, Walsh M, Schoch E, Meltzer SJ, Wright C, Searle J, Young J and Leggett BA (1999) Characterizations of a subtype of colorectal cancer combining features of the suppressor and mild mutator pathways. J Clin Pathol 52: 455–460
Jen J, Kim H, Piantadosi S, Liu Z-F, Levitt RC, Sistonen P, Kinzler KW, Vogelstein B and Hamilton SR (1994a) Allelic loss of chromosome 18q and prognosis of colorectal cancer. N Engl J Med 331: 213–221
Jen J, Powell SM, Papadopoulos N, Smith KJ, Hamilton SR, Vogelstein B and Kinzler KW (1994b) Molecular determinants of dysplasia in colorectal lesions. Cancer Res 54: 5523–5526
Jiricny J (1998) Replication errors: Cha(lle)nging the genome. EMBO J 17: 6427–6436
Kane MF, Loda M, Gaida GM, Lipman J, Mishra R, Goldman H, Jessup JM and Kolodner R (1997) Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and the mismatch repair-defective human tumor cell lines. Cancer Res 57: 808–811
Kim J, Jen J, Vogelstein B and Hamilton SR (1994) Clinical and pathological characteristics of sporadic colorectal carcinomas with DNA replication errors in microsatellite sequences. Am J Pathol 145: 148–156
Kinzler KW and Vogelstein B (1996) Lessons from hereditary colorectal cancer. Cell 87: 159–170
Konishi M, Kikuchi-Yanoshita R, Tanaka K, Muraoka M, Onda A, Okumura Y, Kishi N, Iwama T, Mori T, Koike M, Ushio K, Chiba M, Nomizu S, Konishi F, Utsunomiya J and Miyaki M (1996) Molecular nature of colon tumors in hereditary nonpolyposis colon cancer, familial polyposis, and sporadic colon cancer. Gastroenterology 111: 307–317
Kuismanen SA, Holmberg MT, Salovaara R, de la Chapelle A and Peltomaki P (2000) Genetic and epigenetic modification of MLH1 accounts for a major share of microsatellite-unstable colorectal cancers. Am J Pathol 156: 1773–1779
Lengauer C, Kinzler KW and Vogelstein B (1998) Genetic instabilities in human cancers. Nature 396: 643–649
Levine AJ (1997) p53, the cellular gatekeeper for growth and division. Cell 88: 323–331
Liu B, Farrington SM, Petersen GM, Hamilton SR, Parsons R, Papadopoulos N Fujiwara T, Jen J, Kinzler KW and Wyllie AH (1995) Genetic instability occurs in the majority of young patients with colorectal cancer. Nat Med 1: 348–352
Losi L, Ponz de Leon M, Jiricny J, Di Gregorio C, Benatti P, Percesepe A, Fante R, Roncucci L, Pedroni M and Benhattar J (1997) K-ras and p53 mutations in hereditary non-polyposis colorectal cancers. Int J Cancer 74: 94–96
Lukish JR, Muro K, DeNobile J, Katz R, Williams J, Cruess DF, Drucker W, Kirsch I and Hamilton SR (1998) Prognostic significance of DNA replication errors in young patients with colorectal cancer. Ann Surg 227: 51–56
Lynch HT and Lynch JF (2000) Hereditary nonpolyposis colorectal cancer. Semin Surg Oncol 18: 305–313
Magrath I and Litvak J (1993) Cancer in developing countries: opportunities and challenge. J Natl Cancer Inst 85: 862–874
Moskaluk CA, Heitmiller R, Zahurak M, Schwab B, Sidransky D and Hamilton SR (1996) p53 and p21WAF1/CIP1/SD11gene products in Barrett esophagus and adenocarcinoma of the esophagus and esophago gastric junction. Human Pathol 27: 1211–1220
Moskaluk CA and Kern SE (1997) Microdissection and polymerase chain reaction amplification of genomic DNA from histological tissue sections. Am J Pathol 150: 1547–1552
Muller W, Burgart LJ, Krause-Paulus R, Thibodeau SN, Almeida M, Edmonston TB, Boland CR, Sutter C, Jass JR, Lindblom A, Lubinski J, MacDermot K, Sanders DSA, Morreau H, Muller A, Oliani C, Orntoft T, Ponz De Leon M, Rosty C, Rodgriguez-Bigas M, Ruschoff J, Ruszkiewicz A, Sabourin J, Salovaara R and Moslein G ICG-HNPCC (International Collaborative Group) (accepted for publication) The value of immunohistochemistry in the diagnosis of hereditary nonpolyposis colorectal cancer (HNPCC) – Results of an international collaborative study. Familial Cancer,
Nucci MR, Robinson CR, Longo P, Campbell P and Hamilton SR (1997) Phenotypic and genotypic characteristics of aberrant crypt foci in human colorectal mucosa. Human Pathol 28: 1396–1407
Olschwang S, Hamelin R, Laurent-Puig P, Thuille B, DeRycke Y, Li Y-J, Muzeau F, Girodet J, Salmon RJ and Thomas G (1997) Alternative genetic pathways in colorectal carcinogenesis. Proc Natl Acad Sci USA 94: 12122–12127
Parkin DM, Muir CS, Whelan SL, Gao YT, Ferlay J and Powell J (eds.) (1992) Cancer incidence in five continents. IARC Scientific Publ 120: 182–185
Parsons R, Myeroff LL, Liu B, Willson JK, Markowitz SD, Kinzler KW and Vogelstein B (1995) Microsatellite instability and mutations of the transforming growth factor beta type II receptor gene in colorectal cancer. Cancer Res 55: 5548–5550
Perucho M (1999) Correspondence re: Boland CR et al. A National Cancer Institute workshop on microsatellite instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer (Cancer Res 58: 5248–5257, 1998). Cancer Res 59: 249–253
Peters RK, Garabant DH, Yu MC and Mack TM (1989) A case-control study of occupational and dietary factors in colorectal cancer in young men by subsite. Cancer Res 49: 5459–5468
Prolla TA (1998) DNA mismatch repair and cancer. Curr Opin Cell Biol 10: 311–316
Rembacken BJ, Fuji T, Cairns A, Dixon MF, Yoshida S, Chalmers DM and Axon AT (2000) Flat and depressed colonic neoplasms: A prospective study of 1000 colonoscopies in the UK. Lancet 355: 1211–1214
Richter ED and Safi J (1997) Pesticide use, exposure, and risk: a joint Israeli-Palestinian perspective. Environment Res 73: 211–218
Rockhill B and Giovannucci E (1999) Editorial. Cancer mortality rates in Menofeia, Egypt: comparison with US mortality rates. Cancer Causes and Control 10: 345–347
Rubin BM, Doman DB, Goldberg HJ and Golding MI (1998) Colon cancer in young persons of East African descent. Am J Gastroenterol 93: 1014–1015
Ruschoff J, Dietmaier W, Luttges J, Seitz G, Bocker T, Zirngibl H, Schlegel J, Schackert HK, Jauch KW and Hofstaedter F (1997) Poorly differentiated adenocarcinoma, medullary type: clinical, phenotypic, and molecular characteristics. Am J Pathol 150: 1815–1825
Servomaa K, Kiuru A, Kosma V-M, Hirvikoski P and Rytomaa T (2000) p53 and K-ras gene mutations in carcinoma of the rectum among Finnish women. J Clin Pathol Mol Pathol 53: 24–30
Soliman AS, Bondy ML, Levin B, Hamza MR, Ismail K, Ismail S, Hammam HM, el-Hattab OH, Kamal SM, Soliman AG, Dorgham LA, McPherson RS and Beasley RP (1997a) Colorectal cancer in Egyptian patients under 40 years of age. Int J Cancer 71: 26–30
Soliman AS, Smith MA, Cooper SP, Ismail K, Khaled H, Ismail S, McPherson RS, Seifeldin IA and Bondy ML (1997b) Serum organochlorine pesticide levels in patients with colorectal cancer in Egypt. Arch Environ Health 52: 409–415
Soliman AS, Bondy ML, Guan Y, El-Badawi S, Mokhtar N, Bayomi S, Raouf AA, Ismail S, McPherson RS, Abdel-Hakim TF, Beasley RP, Levin B and Wei Q (1998a) Reduced expression of mismatch repair genes in colorectal cancer patients in Egypt. Int J Oncol 12: 1315–1319
Soliman AS, Bondy ML, Levin B, El-Badawy S, Khaled H, Hablas A, Ismail S, Adley M, Mahgoub KG, McPherson RS and Beasley RP (1998b) Familial aggregation of colorectal cancer in Egypt. Int J Cancer 77: 811–816
Soliman AS, Bondy ML, Raouf AA, Makram MA, Johnston DA and Levin B (1999) Cancer mortality in Menofeia, Egypt: comparison with U.S. mortality rates. Cancer Causes and Control 10: 349–354
Statistical Analysis System User's Guide: Basics Version 6.0. (1990) Cary, North Carolina: Statistical Analysis System Institute, Inc
Steele GD Jr. (1994) The National Cancer Data Base report on colorectal cancer. Cancer 74: 1979–1989
Tang W-Y, Elnatan J Lee Y-S, Goh H-S and Smith DR (1999) c-Ki- ras mutations in colorectal adenocarcinomas from a country with a rapidly changing colorectal cancer incidence. Br J Cancer 81: 237–241
Temtamy SA, Kandil MR, Demerdash AM, Hassan WA, Meguid NA and Afifi HH (1994) An epidemiological/genetic study of mental subnormality in Assiut Governorate, Egypt. Clin Genet 46: 347–351
Umetani N, Sasaki S, Watanabe T, Shinozaki M, Matsuda K, Ishigami H, Ueda E and Muto T (1999) Genetic alterations in ulcerative colitis-associated neoplasia focusing on APC, K-ras gene and microsatellite instability. Jpn J Cancer Res 90: 1081–1087
Vasen HFA, Mecklin JP, Kahn PM and Lynch HT (1991) Hereditary non-polyposis colorectal cancer. Lancet 338: 877
Weisburger JH, Reddy BS and Spingarn NE (1980) Current views on the mechanisms involved in the etiology of colorectal cancer. In: Colorectal Cancer: Prevention, Epidemiology, and Screening, S Winawer, D Schottenfeld and P Sherlock (eds.) pp. 19–41. Raven Press: New York
Wijnen J, Khan PM, Vasen H, van der Klift H, Mulder A, van Leeuwen-Cornelisse I, Bakker B, Losekoot M, Moller P and Fodde R (1997) Hereditary nonpolyposis colorectal cancer families not complying with the Amsterdam criteria show extremely low frequency of mismatch repair gene mutations. Am J Hum Genet 61: 329–335
Williams PR, Stegens NL and Goldsmith JR (1977) Associations of cancer site and type with occupation and industry from the Third National Cancer Survey Interview. J Natl Cancer Inst 59: 1147–1185
Yagi OK, Akiyama Y, Nomizu T, Iwama T, Endo M and Yuasa Y (1998) Proapoptotic gene BAX is frequently mutated in hereditary nonpolyposis colorectal cancer but not in adenomas. Gastroenterology 114: 268–274
Zhang R, Takahashi S, Orita S, Yoshida A, Maruyama H, Shirai T and Ohta N (1998) p53 gene mutations in rectal cancer associated with schistosomiasis japonica in Chinese patients. Cancer Lett 131: 215–221
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Soliman, A., Bondy, M., El-Badawy, S. et al. Contrasting molecular pathology of colorectal carcinoma in Egyptian and Western patients. Br J Cancer 85, 1037–1046 (2001). https://doi.org/10.1054/bjoc.2001.1838
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1054/bjoc.2001.1838
Keywords
This article is cited by
-
Clinicopathological features of Egyptian colorectal cancer patients regarding somatic genetic mutations especially in KRAS gene and microsatellite instability status: a pilot study
Egyptian Journal of Medical Human Genetics (2019)
-
Colorectal cancer in a patient with intestinal schistosomiasis: a case report from Kilimanjaro Christian Medical Center Northern Zone Tanzania
World Journal of Surgical Oncology (2017)
-
Clinicopathological patterns and challenges of management of colorectal cancer in a resource-limited setting: a Tanzanian experience
World Journal of Surgical Oncology (2013)
-
Pattern of clinically relevant mutations in consecutive series of Russian colorectal cancer patients
Medical Oncology (2013)
-
The CpG island methylator phenotype may confer a survival benefit in patients with stage II or III colorectal carcinomas receiving fluoropyrimidine-based adjuvant chemotherapy
BMC Cancer (2011)